Tegnap a Prilenia webináriumot tartott a Pridopidinnel végzett III. fázisú vizsgálatról. Köszönjük mindenkinek, aki csatlakozott, és külön köszönet az előadóinknak, Michael Haydennek, Andrew Feiginnek, Ralf Reilmannak és Anne Rossernek, valamint Dina de Sousának az Európai Huntington Szövetség részéről. Maradjanak velünk, hogy további eseményeket láthassanak a májusi tudatossági hónap során! 
Dimitri Poffé is an already known member of the HD Community. After testing positive for Huntington’s Disease, Dimitri embraced a bicycle journey through South America. In this project, called Explore for Huntington, Dimitri visited several Bővebben......
December 2, 2024 – PTC to receive $1.0B in cash at closing –– PTC is eligible to receive up to $1.9B in development, regulatory and sales milestones –– PTC to share profits in the U.S. and tiered double-digit royalties on ex-U.S. net Bővebben......
The Phase 2 DIMENSION Study did not meet its primary endpoint Dalzanemdor was generally well-tolerated; no new safety signals were observed Based on these data, the Company does not plan further development of dalzanemdor CAMBRIDGE, Bővebben......
Hungarian 
English 
Arabic 
Bulgarian 
Chinese 
Czech 
Danish 
Dutch 
Estonian 
Finnish 
French 
German 
Greek 
Indonesian 
Italian 
Japanese 
Latvian 
Lithuanian 
Polish 
Portuguese 
Romanian 
Russian 
Slovak 
Slovenian 
Spanish 
Swedish 
Turkish 
Ukrainian
0 hozzászólás